Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (Weighted Average) (2024 - 2025)

Phaos Technology Holdings (Cayman) (POAS) reported Shares Outstanding (Weighted Average) of $2.1 million for Q4 2025, down 89.25% quarter-over-quarter from $19.2 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Shares Outstanding (Weighted Average) (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) has reported Shares Outstanding (Weighted Average) for 2 years, with the latest figure at $2.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Oct 2025 stood at $2.1 million (changed N/A YoY), and the FY2025 full-year result was $2.1 million, down 88.2% from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 stood at $2.1 million, down from $19.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $19.2 million in Q2 2025, with the low at $2.1 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 1.74 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 382.90 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 1.28 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 1.48 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 579.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 385.10 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 456.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 98.20 Mn
10 Phaos Technology Holdings (Cayman) 682,234.12 627,245.12 - 2.06 Mn

Historic Data

Download Data
DateValue
Oct 31, 2025 2.06 Mn
Apr 30, 2025 19.20 Mn
Apr 30, 2024 17.48 Mn